European Pharmaceutical Review Issue 2 2021
Posted: 15 April 2021 | European Pharmaceutical Review | No comments yet
European Pharmaceutical Review’s latest journal features articles discussing the challenges and potential of antibody-drug conjugates, innovations in cleanroom infrastructure and why we need to test for heavy metal contaminants in cannabis vaping aerosols. Also in the issue, an exploration of how risk-sharing strategies could help expedite access to COVID-19 vaccines, a discussion of the regulatory requirements for analytical balances operating in GMP and GLP laboratories and so much more…
Also in Issue 2:
- FORMULATION, DEVELOPMENT & DELIVERY
Nanoparticles for drug delivery: next-generation biological drugs to treat inflammatory bowel diseases
Fabrice Navarro, CEA-Leti - QA/QC & ANALYTICAL TECHNIQUES
Implementation of trending charts in analysis of inventory pattern
Mostafa Eissa, Cairo University
Optimising analytical separations of synthetic RNA with modified HPLC
Anastassia Kanavarioti, Yenos Analytical LLC, and Sandra Rontree, Thermo Fisher Scientific - MANUFACTURING, PACKAGING & LOGISTICS
COVID-19 vaccine rollout: a logistics success story
Zoe McLernon, Logistics UK
Plasma-derived therapies require a mastery of advanced bioproduction techniques
Carole Resman, LFB - BIOPROCESSING & BIOPRODUCTION
A new small molecule drug discovery and development platform for HLA-associated autoimmune diseases
Ryan Schutte and Robert Perni, IM Therapeutics
The rest of this content is restricted - login or subscribe free to access
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here